Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 08, 2019

SELL
$175.89 - $279.23 $68,597 - $108,899
-390 Closed
0 $0
Q2 2019

Aug 14, 2019

SELL
$250.96 - $284.94 $1.51 Million - $1.71 Million
-6,000 Reduced 93.9%
390 $102,000
Q1 2019

May 14, 2019

SELL
$276.39 - $362.25 $297,119 - $389,418
-1,075 Reduced 14.4%
6,390 $1.83 Million
Q4 2018

Feb 13, 2019

SELL
$281.08 - $444.25 $44,410 - $70,191
-158 Reduced 2.07%
7,465 $2.43 Million
Q3 2018

Nov 13, 2018

SELL
$354.53 - $449.75 $62,751 - $79,605
-177 Reduced 2.27%
7,623 $3.43 Million
Q2 2018

Aug 10, 2018

BUY
$278.07 - $446.21 $1 Million - $1.61 Million
3,600 Added 85.71%
7,800 $3.19 Million
Q1 2018

May 14, 2018

BUY
$192.49 - $295.85 $808,458 - $1.24 Million
4,200 New
4,200 $1.22 Million

Others Institutions Holding ABMD

About ABIOMED INC


  • Ticker ABMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 45,460,900
  • Description
  • Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...
More about ABMD
Track This Portfolio

Track Credit Agricole S A Portfolio

Follow Credit Agricole S A and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Agricole S A, based on Form 13F filings with the SEC.

News

Stay updated on Credit Agricole S A with notifications on news.